Related Experiment Video
Updated: Aug 19, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Compelling nature of arterial manifestations in Behcet disease
Zafer H Iscan1, Kerem M Vural, Murat Bayazit
1Department of Cardiovascular Surgery, Turkiye Yuksek Ihtisas Hospital, 06100 Sihhiye-Ankara, Turkey. Zafirustr@yahoo.com
Insights
Surgical treatment for arterial complications in Behcet disease (vasculo-Behcet disease) can be life-saving, especially for ruptured aneurysms. However, long-term outcomes are challenging, emphasizing careful patient selection and surgical technique.
Area of Science:
- Vascular Surgery
- Rheumatology
- Behcet Disease Management
Background:
- Behcet disease frequently involves arterial complications, termed vasculo-Behcet disease.
- Arterial manifestations, including pseudoaneurysms and critical limb ischemia, pose significant surgical challenges.
Purpose of the Study:
- To review surgical treatment experiences for arterial complications in vasculo-Behcet disease.
- To analyze long-term results and identify pitfalls of surgical interventions.
Main Methods:
- Retrospective analysis of 20 consecutive patients undergoing surgery for vasculo-Behcet disease between 1990 and 2003.
- Data collection on operative procedures, outcomes, and long-term follow-up.
Main Results:
- Thirty-four operations were performed with a 5.8% operative mortality rate.
- 17 emergency operations were necessitated, including 6 for ruptured abdominal aneurysms.
- Long-term survival rates were low: 10-year survival was 30%, and complication-free survival was 13%.
Conclusions:
- Aggressive surgical management can be life-saving for emergent arterial complications in vasculo-Behcet disease.
- Surgical outcomes are negatively impacted by active inflammation during intervention.
- Optimizing results requires individualized approaches, disease-free surgical sites, and avoidance of autologous grafts.
Introduction:
We present our experience with surgical treatment of arterial complications in Behcet disease (vasculo-Behcet disease), and the long-term results and pitfalls of surgical treatment.
Material And Methods:
Between January 1990 and January 2003, 20 consecutive patients underwent surgery to treat vasculo-Behcet disease. Most patients (17 of 20) were men, with mean age of 38.4 years.
Results:
Thirty-four operations were performed in 20 patients. The operative mortality rate was 5.8% (2 patients). There were 17 emergency operations, 6 because of ruptured primary abdominal aneurysms. There were five others with critical limb ischemia, resulting in 3 amputations. All patients were followed up postoperatively on average for 44 months (range, 6 months-14 years). Two additional patients were lost to follow-up. After the initial operation 10-year survival rate was 30%, 10-year complication-free survival rate was 13%, and 5-year repeat operation-free survival rate was 26%.
Conclusion:
Although surgical intervention should be postponed until active inflammation has subsided, often this is not possible, because of the emergent nature of these problems. Most arterial complications of vasculo-Behcet disease present with a pseudoaneurysm rupture or with impending rupture. An aggressive surgical approach can be life-saving in such instances, and should be undertaken regardless of long-term complications, which are more common when the operation is performed in the presence of active inflammation. Early and late results can be improved by individualizing, selecting a disease-free area for reconstruction, and eliminating use of autologous graft material.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Endocarditis II: Clinical Features of Infective Endocarditis
Hypertension III: Clinical Manifestations and Diagnostic Studies
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease III: Clinical Manifestations